These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16582488)

  • 1. Crystallization and preliminary X-ray diffraction studies on the human Plk1 Polo-box domain in complex with an unphosphorylated and a phosphorylated target peptide from Cdc25C.
    García-Alvarez B; Ibañez S; Montoya G
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):372-5. PubMed ID: 16582488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization.
    García-Alvarez B; de Cárcer G; Ibañez S; Bragado-Nilsson E; Montoya G
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3107-12. PubMed ID: 17307877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype.
    McInnes C; Estes K; Baxter M; Yang Z; Farag DB; Johnston P; Lazo JS; Wang J; Wyatt MD
    Mol Cancer Ther; 2012 Aug; 11(8):1683-92. PubMed ID: 22848093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polo-box domain: a versatile mediator of polo-like kinase function.
    Park JE; Soung NK; Johmura Y; Kang YH; Liao C; Lee KH; Park CH; Nicklaus MC; Lee KS
    Cell Mol Life Sci; 2010 Jun; 67(12):1957-70. PubMed ID: 20148280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.
    Yun SM; Moulaei T; Lim D; Bang JK; Park JE; Shenoy SR; Liu F; Kang YH; Liao C; Soung NK; Lee S; Yoon DY; Lim Y; Lee DH; Otaka A; Appella E; McMahon JB; Nicklaus MC; Burke TR; Yaffe MB; Wlodawer A; Lee KS
    Nat Struct Mol Biol; 2009 Aug; 16(8):876-82. PubMed ID: 19597481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polo-box domains confer target specificity to the Polo-like kinase family.
    van de Weerdt BC; Littler DR; Klompmaker R; Huseinovic A; Fish A; Perrakis A; Medema RH
    Biochim Biophys Acta; 2008 Jun; 1783(6):1015-22. PubMed ID: 18359294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis of phosphopeptide binding to the polo-box domain of the mitotic kinase PLK1 using molecular dynamics simulation.
    Huggins DJ; McKenzie GJ; Robinson DD; Narváez AJ; Hardwick B; Roberts-Thomson M; Venkitaraman AR; Grant GH; Payne MC
    PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20711360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of the polo-box domain of human Polo-like kinase 2.
    Kim JH; Ku B; Lee KS; Kim SJ
    Proteins; 2015 Jul; 83(7):1201-8. PubMed ID: 25846005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation.
    Lasek AL; McPherson BM; Trueman NG; Burkard ME
    PLoS One; 2016; 11(2):e0150225. PubMed ID: 26919439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain.
    Yan F; Liu G; Chen T; Fu X; Niu MM
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31892137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1.
    Srinivasrao G; Park JE; Kim S; Ahn M; Cheong C; Nam KY; Gunasekaran P; Hwang E; Kim NH; Shin SY; Lee KS; Ryu E; Bang JK
    PLoS One; 2014; 9(9):e107432. PubMed ID: 25211362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting.
    Hanisch A; Wehner A; Nigg EA; Silljé HH
    Mol Biol Cell; 2006 Jan; 17(1):448-59. PubMed ID: 16267267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain.
    Park JE; Kim TS; Kim BY; Lee KS
    Cell Cycle; 2015; 14(22):3624-34. PubMed ID: 26513691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Molecular Design of Potent PLK1 PBD Domain-binding Phosphopeptides Using Preferential Amino Acid Building Blocks.
    Mao XL; Wang KF; Zhu F; Pan ZH; Wu GM; Zhu HY
    Chem Biodivers; 2016 Aug; 13(8):1103-10. PubMed ID: 27450535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells.
    Qian WJ; Park JE; Lim D; Lai CC; Kelley JA; Park SY; Lee KW; Yaffe MB; Lee KS; Burke TR
    Biopolymers; 2014 Nov; 102(6):444-55. PubMed ID: 25283071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pinning down the polo-box domain.
    Lee KS; Idle JR
    Chem Biol; 2008 May; 15(5):415-6. PubMed ID: 18482691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of mammalian polo-like kinase 1 (Plk1) localization: self- versus non-self-priming.
    Lee KS; Park JE; Kang YH; Zimmerman W; Soung NK; Seong YS; Kwak SJ; Erikson RL
    Cell Cycle; 2008 Jan; 7(2):141-5. PubMed ID: 18216497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying Plk1 polo-box domain-mediated biological processes and their physiological significance.
    Lee KS; Park JE; Kang YH; Kim TS; Bang JK
    Mol Cells; 2014 Apr; 37(4):286-94. PubMed ID: 24722413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity.
    Murugan RN; Park JE; Kim EH; Shin SY; Cheong C; Lee KS; Bang JK
    Mol Cells; 2011 Sep; 32(3):209-20. PubMed ID: 21809214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
    Tsvetkov L; Stern DF
    Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.